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Objectives: Adverse effects have been reported of prenatal and/or postnatal passive exposure to smoking
on children’s health. Uncertainties remain about the relative importance of smoking at different periods in
the child’s life. We investigate this in a pooled analysis, on 53 879 children from 12 cross-sectional
studies—components of the PATY study (Pollution And The Young).
Methods: Effects were estimated, within each study, of three exposures: mother smoked during pregnancy,
parental smoking in the first two years, current parental smoking. Outcomes were: wheeze, asthma,
‘‘woken by wheeze’’, bronchitis, nocturnal cough, morning cough, ‘‘sensitivity to inhaled allergens’’ and
hay fever. Logistic regressions were used, controlling for individual risk factors and study area.
Heterogeneity between study-specific results, and mean effects (allowing for heterogeneity) were estimated
using meta-analytical tools.
Results: There was strong evidence linking parental smoking to wheeze, asthma, bronchitis and nocturnal
cough, with mean odds ratios all around 1.15, with independent effects of prenatal and postnatal
exposures for most associations.
Conclusions: Adverse effects of both pre- and postnatal parental smoking on children’s respiratory health
were confirmed. Asthma was most strongly associated with maternal smoking during pregnancy, but
postnatal exposure showed independent associations with a range of other respiratory symptoms. All
tobacco smoke exposure has serious consequences for children’s respiratory health and needs to be
reduced urgently.
C
onsiderable attention has focused recently on the
harmful effects of involuntary or ‘‘passive’’ smoking.
Many studies have reported adverse effects of prenatal
and/or postnatal exposure on children’s respiratory health,
with much of the literature summarised in a number of
reviews.1–4 Within a broad picture of harmful effects,
uncertainties remain, including the relative importance of
exposure at different periods in the child’s life.
There is some evidence that prevalence of wheeze in
childhood is associated more strongly to prenatal (intrauter-
ine) exposure than with current parental smoking.5–9 In the
Italian study of Agabiti et al, the effect of current parental
smoking on wheeze was evident only in adolescents but not
among younger children, while the effect of maternal
smoking during pregnancy was greater in children.10 A
Polish study found current exposure a stronger predictor
than prenatal exposure,11 while a study in Chicago found a
protective association with current maternal smoking.12
Similar inconsistencies have been seen for effects of tobacco
exposure on child’s asthma and other respiratory outcomes.2 4
Several studies have shown protective effects of current
parental smoking on atopy, or on atopic-related conditions
such as eczema or hay fever.13–16 Yet Lam et al found increased
risks of hay fever related to passive smoking,15 and passive
smoking was also associated with allergic rhinoconjunctivitis
and hay fever among Swedish and Turkish schoolchil-
dren.17 18
The Pollution And The Young (PATY) project assembled
data on exposures and health for 58 561 children, from cross-
sectional studies carried out in 12 countries with comparable
questionnaires. PATY was established primarily to investigate
associations between air pollution and respiratory health.
Here we use that subset of 53 879 children with information
on parental smoking. This pooled analysis, on extensive,
original data (with only three of the 12 studies as yet
published on this topic),19–21 gives a powerful opportunity to
examine critical periods of exposure to cigarette smoke, to
address the problems of co-linearity between prenatal and
postnatal passive smoking and to assess independent effects
of three exposures: maternal smoking during pregnancy,
passive smoking during the first two years of the child’s life,
and current passive smoking. Associations found in this large
dataset between prenatal and postnatal passive smoking on
children’s lung function have already been reported.22
METHODS
Comparable cross-sectional studies were sought (published
or otherwise), which assessed respiratory symptoms and
individual risk factors at elementary school age by compar-
able parent’s questionnaires,23 included cough and wheeze as
primary outcomes, and (since a primary objective was to
assess effects of ambient air pollution) allowed calculation of
annual mean particulate matter. To improve comparability
further, data were restricted to children aged 6–12 years.
Table 1 describes the contributing studies, detailed in
individual reports.10 19 20 24–29
All studies collected data on the children’s health and
individual/household risk factors (including exposure to
tobacco smoke) via questionnaires, distributed in schools
and filled in by the parents. Care was taken to select or
construct variables which were as comparable as possible.23
Eight outcomes were analysed: wheeze in the last
12 months, ‘‘woken by wheeze in the last 12 months’’,
asthma ever, bronchitis in the last 12 months, nocturnal
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dry cough in the last 12 months, morning cough, ‘‘sensitivity
to inhaled allergens’’, and hay fever ever. Detailed wordings
are reported elsewhere.23 Three ‘‘parental smoking’’ measures
were defined: mother smoked during pregnancy, child lived
with a smoker during the first two years of life (unavailable
for Austria and Switzerland, in Germany ‘‘first year of life’’),
and child currently lives with a smoker. The latter included
all smokers in the household, in all countries. Passive
smoking during the first two years was restricted to parental
smoking in Italy, Switzerland and the CESAR (Central
European Study on Air pollution and Respiratory health)
countries.
Only the exposures relate to different periods of the child’s
life. Health questionnaires were administered only once per
child.
Statistical analyses
Analyses were done using STATA v8. A two-stage approach
was used. In stage 1, study-specific parental smoking effects
were estimated using logistic regression (on individual level
records). Three models were used: The first (‘‘confounder
adjusted’’) controlled for potential confounders (listed
below), but not for the other smoking variables. The second
and third models additionally adjusted for one and then both
other smoking variables. In stage 2, the study specific results
were entered into a meta-analysis, to obtain forest plots of
the estimates, a mean estimate (a weighted mean of the
study specific estimates), and a measure and Cochran x2 test
of between-study heterogeneity. Study specific estimates
were assumed to follow a random distribution about a mean,
and the estimation of this mean and its confidence interval
took into account both variation among study-specific
estimates and uncertainty (due to sampling variability)
related to each study-specific estimate.30
We controlled for age, sex, maternal education, paternal
education, nationality, household crowding, gas for cooking,
unvented gas/oil/kerosene heater, mould, birth order, ‘‘ever
had a pet’’, and study area. Adjusting for study area accounts
for risk factors such as ambient air pollution, climate, and
neighbourhood socioeconomic differences.
Meta-regressions assessed associations between study-
specific estimates and study-characteristics. These potential
sources of heterogeneity between estimates were: season of
data collection; study period; proportion of younger children
(6–8 years old); response rate (above/below 80%); Western or
former ‘‘Eastern Block’’ countries.
We tested robustness of results to controlling for parental
illness (a potentially problematic variable, since parental
smoking may cause both parent’s and child’s illness),
attendance at kindergarten, and breastfeeding. We also
assessed effect modification by age (6–8 v 9–12), breastfeed-
ing, household crowding and, since a recent study found that
associations between maternal smoking during pregnancy
and asthma were restricted to girls,31 for effect modification
by the child’s sex.
RESULTS
Table 2 shows study characteristics, frequency of exposure to
passive smoking, and prevalences of respiratory and allergic
disorders. Bronchitis was reported most frequently, preva-
lences exceeding 30% in four of the studies. Hay fever and
‘‘woken by wheeze in the last 12 months’’ were reported least
frequently, with prevalences under 10% in most studies.
Numbers living with a reported current smoker ranged
from 45.8% in Germany to 70.9% in Bulgaria. Passive
smoking during the first two years of life ranged from
18.7% in Germany (first year of life only), then from 46.3% in
Russia, to 74.8% in Poland. Reported prenatal exposure
tended to be rarer in Eastern countries and ranged from 4.4%
in Russia to 28.7% in Holland.
The exposures were correlated, as anticipated. Coefficients
of correlation (r) between current exposure and exposure
during the first two years ranged from 0.22 in Germany to
0.75 in the Czech Republic. Between prenatal exposure and
exposure in the first two years, r ranged from 0.16 in Bulgaria
to 0.42 in North America and the Netherlands, and between
current and prenatal exposure, r ranged from 0.14 in Bulgaria
to 0.42 in North America.
Confounder adjusted results
Wheeze and nocturnal cough were associated with all three
smoking measures, with harmful effects seen in nearly all
studies (fig 1). Mean odds ratios for wheeze ranged from 1.17
(95% confidence interval (CI) 1.02 to 1.33) for the effect of
smoking during the first two years, to 1.25 (95% CI 1.14 to
1.37) for smoking during pregnancy (table 3).
There was evidence of heterogeneity (within a strong
predominance of positive results) among results for both
current smoking and smoking during the first two years.
Mean odds of nocturnal cough were raised by around 12% for
all three smoking variables, with no evidence of hetero-
geneity.
Asthma was clearly related to smoking during pregnancy,
with a mean odds ratio of 1.18 (95% CI 1.08 to 1.28). Odds
ratios for the other periods of exposure were also above one
in nine of the 12 countries, with no evidence of hetero-
geneity.
Associations between current smoking and ‘‘woken by
wheeze’’ were predominantly positive, with a mean odds
ratio of 1.12 (95% CI 0.99 to 1.25). For the other two smoking
Table 1 Participating studies: geographic units, period of data gathering, and number of
children, aged 6–12 years, with information on age, sex, and parental smoking
Study Number of study areas Data collection
Number of
children
Age range
(years)
Austria, Linz Survey 8 areas in 1 town Jan 1996–Dec 1998 3776 6–8
Bulgaria, CESAR study 4 areas in 3 towns Feb–May 1996 2973 7–11
Czech Republic, CESAR study 4 areas in 1 town Feb–May 1996 2962 7–11
Germany, Bitterfeldt study 3 areas in 3 towns Aug 1992–Jul 1993 1972 6–12
Hungary, CESAR study 5 areas in 5 towns Feb–May 1996 3031 7–11
Italy, Sidria study 29 areas in 22 towns Oct 1994–Mar 1995 9073 6–10
Holland, 24 school study 24 areas in 19 towns Apr 1997–Jul 1998 1913 7–12
North America, 24 city study 24 areas in 24 towns Sep–Nov in 1988–90 14845 8–11
Poland, CESAR study 4 areas in 4 towns Feb–May 1996 2643 7–11
Russia, 10-city study 13 areas in 10 towns Apr–May 1999 5412 8–12
Slovakia, CESAR study 4 areas in 3 towns Feb–May 1996 2531 7–11
Switzerland, Scarpol study 10 areas in 10 towns Oct 1992–Mar 1993 2748 6–12
Total 132 areas in 105 towns 53879
CESAR, Central European Study on Air pollution and Respiratory health.
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measures results were less clear—mean associations were
positive, but with considerable heterogeneity.
Bronchitis was related to current smoking, and to smoking
during the first two years, with mean odds ratios of about
1.10 (fig 2). Associations of bronchitis with smoking during
pregnancy were heterogeneous, within no clear pattern.
For all three exposures, effect estimates for hay fever were
predominantly negative, with Russia the main exception
(fig 2). Mean odds ratios for both the effect of smoking
during the first two years and of smoking during pregnancy
were around 0.90. The Russian estimate for current smoking
was large, giving rise to some between study heterogeneity
(p = 0.10).
Effect estimates of current smoking on ‘‘sensitivity to
inhaled allergens’’ showed some apparently protective effect,
with mean odds ratio of 0.96 (95% CI 0.91 to 1.02). For
smoking during pregnancy, and smoking during the first two
years, estimates tended to be small and mean odds ratios
essentially null.
Mean effect estimates for morning cough were positive for
all exposures, up to 1.12 (95% CI 0.99 to 1.27) for smoking
during the first two years, but with heterogeneity between
studies within unclear patterns of association.
Few consistent associations were seen between study
specific results and potential sources of heterogeneity tested,
and differences between groups of studies were generally
small. Odds ratios tended to be inversely related to the
proportion of younger children in the study. For smoking
during pregnancy, estimates were higher in the later studies
for most outcomes, and also in the studies with lower
response rates (categorisations which overlapped consider-
ably).
Independent effects of the exposure periods
For most of the outcomes strongly associated with smoking
during pregnancy (wheeze, asthma, hay fever), associations
remained robust to all adjustments. For nocturnal cough, the
association became of borderline statistical significance.
Mean, fully-adjusted odds ratios were 0.89 (95% CI 0.80 to
1.00) for hay fever, and around 1.15 for these other four
outcomes (table 3).
Of those outcomes most strongly associated with smoking
during the first two years of life (wheeze, asthma, bronchitis,
nocturnal cough, hay fever), associations with bronchitis,
wheeze and nocturnal cough were independent of smoking
during pregnancy (data not shown), but were weakened in
the fully adjusted model.
For current smoking, associations with bronchitis and
‘‘woken by wheeze’’ remained robust after all adjustments
(table 3). Those for wheeze and nocturnal cough were
independent of smoking during pregnancy (data not shown),
and odds ratios remained raised after all adjustments, albeit
not statistically significant. The mean odds ratio for asthma
was considerably reduced by these adjustments.
Sensitivity analyses
There was no consistent effect modification by age within the
individual studies.
In more crowded households than less crowded ones mean
effects were greater for wheeze, bronchitis, and both coughs,
but lower for asthma and sensitivity to inhaled allergens. The
strongest interaction was found for morning cough: a mean
odds ratio 17% higher (95% CI 21% to 39%) in crowded
households than in less crowded ones.
In those studies for which parental illness data were
available, parental allergy did not confound associations
between child’s ‘‘sensitivity to inhaled allergens’’ and
parental smoking, nor parental lung disease for nocturnal
cough, nor parental asthma for child’s asthma. For hay fever,
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some odds ratios changed a little towards the null on
adjusting for parental allergy, and similarly for bronchitis and
morning cough, on adjusting for parental lung disease (data
not shown). Neither attendance at kindergarten nor breast-
feeding had any confounding effect.
Child’s sex was not a strong modifier of effects of maternal
smoking in pregnancy. Contrary to Alati’s findings,31 the
mean odds ratio for asthma was higher in boys: 1.24 (95% CI
1.12 to 1.38) versus 1.10 (95% CI 0.95 to 1.27) in girls.
However, outcome- and country-specific interactions were
generally small and varied in direction. There was little
evidence of breastfeeding modifying the effect of either
postnatal exposure, particularly for smoking in the first two
years of life. For current exposure, the strongest evidence was
seen for wheeze where, in six of nine countries, stronger
effects of exposure were seen among children who were
breastfed (the great majority of the children) than in those
who were not. (This pattern was little changed by controlling
for other smoking measures, or the interaction between
breastfeeding and smoking in the first two years of life.) The
interaction was statistically significant in Bulgaria and
Germany, and the mean of the nine interaction terms was
also statistically significant. In the German dataset, the
existing, apparently protective effect became more pro-
nounced among children not breastfed, with a null effect
among breastfed children. We tested these results by
restricting the analysis to children who were breastfed, and
testing for a trend in environmental tobacco smoke (ETS)
effect across length of breastfeeding. The resulting interac-
tion terms bore no correspondence to the interactions seen
with the yes/no breastfeeding variable.
DISCUSSION
Adverse effects of parental smoking were seen with
considerable consistency for several health outcomes, in
particular asthma, wheeze, bronchitis, and nocturnal cough.
By contrast, negative effects predominated for hay fever,
though results were available for fewer studies, and based on
fewer cases.
Correlations between exposures hamper efforts to distin-
guish between their effects. But generally, odds ratios for our
three exposure periods remained raised (if with reduced
statistical significance) after mutual adjustment, demonstrat-
ing some independence of effect. Maternal smoking during
pregnancy showed independent effects particularly on
wheeze, asthma, nocturnal cough and (inversely) hay fever.
Distinguishing between effects of early-life and current
exposure proved harder. But estimated effects of postnatal
exposure on wheeze, bronchitis and nocturnal cough were
independent of smoking during pregnancy.
Smoking in pregnancy has been linked to low birth weight,
which in turn is linked to later morbidity.1 4 32 Details of
possible harmful mechanisms of smoking during pregnancy
have been discussed elsewhere, including alterations in the
pulmonary neuroendocrine system, reduced lung volume,
reduced number of lung saccules, and reduced length of
elastin fibres in the lung interstitium, resulting in a loss of
lung elasticity.1 33 34
If respiratory diseases of children or parents lead to
smoking cessation, this may result in underestimation of
effects of tobacco smoke in cross-sectional studies and could
even cause inverse swings in observed associations (the
‘‘healthy smoker’’ effect). Observed effects would combine
real exposure effects and inverse behavioural effects and, for
outcomes where true effects are small, behavioural effects
could predominate. Observed negative associations between
smoking and hay fever could be related to these behavioural
effects, rather than to some true protective effect. For asthma
and respiratory symptoms behavioural effects have to be
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assumed as well; however, the adverse effects of tobacco
smoke on these outcomes seems to be much larger and
therefore are not masked by behavioural effects.
We rely on parents’ questionnaire answers, both for
exposure and outcome. Prevalences of smoking in pregnancy
were noticeably low in Russia and (apart from Poland)
Eastern Europe, and we do not have external data by which
to check this, though the consistency across these Eastern
countries gives some reassurance. Smokers misclassifying
themselves as non-smoking would probably cause under-
estimation of effects (unless parents of healthy children
misclassified themselves more). Since all studies were
explicitly focused on outdoor air pollution, self-misclassifica-
tions may have been few. There is evidence of reasonable
validity of parental responses on smoking, and validation
studies carried out in several countries have found a strong
correlation between passive smoking exposure in children
assessed by measuring the level of urinary cotinine and the
amount of parental self-report smoking.1 21 However, parental
smokers under-report cough, and among children with
asthmatic symptoms, smokers’ children are less likely to be
diagnosed asthmatic than non-smokers’ children.35 36 Such
outcome misclassifications would also tend to cause under-
estimation of effects.
The relative importance of pre- and postnatal exposure is
under debate. We were concerned whether our blunt yes/no
exposure measures were adequate in teasing apart the effects
of different periods. ‘‘Maternal smoking in pregnancy’’, for
example, may be thought partly to represent residual effects
of heavy current smoking. For three primary outcomes
(asthma, wheeze and bronchitis) we repeated analyses for
the effects of smoking during pregnancy among the subset of
children with no current exposure, and likewise for the
effects of current smoking, in children whose mothers did
not smoke in pregnancy. All six analyses showed clear
adverse effects (data not shown). We were reassured about
interpreting our primary results, guided by consistency and
relative strength of evidence seen for effects of exposures at
different periods. Recent studies—for example, Kharrazi et
al37—have found harmful effects on the children of the
mother’s passive smoking during pregnancy. This exposure
was not assessed in most of the PATY studies and could not
be analysed here. Evidence that breastfeeding might modify
the effect of exposure was tenuous. There was not a clear
dose–response relationship, suggesting that the variable
might only be an indicator for something else, or that
apparent modifications were chance findings.
Selected outcomes had similar questionnaire wordings
across studies, except for asthma, where, for example, some
referred to the doctor’s diagnosis, others did not.23 Study
specific results proved independent of reference to diagnosis
(data not shown). Lack of power prevented comparisons
across other wording differences. We note that, even given
identical wordings, interpretation and diagnosis of ‘‘asthma’’
may vary between, even within, studies.38
Cross-sectional studies have limitations, but can access far
more individuals than is usually feasible in cohort studies.
Evidence on independent effects of pre- and postnatal passive
smoking from cohort studies is sparse. A recent Norwegian
cohort study was the first to show that prenatal and postnatal
passive smoking induce lasting vulnerability for developing
asthma or respiratory symptoms in adults (significant for
exposure to maternal smoking, but not that of other
household members).39 Independent effects of prenatal
smoking remained difficult to assess in this cohort because
of small numbers.
In conclusion, the large cross-sectional dataset of the PATY
study allowed us to assess independent effects of exposures
to passive smoking at different times of a child’s life, which
had been proven difficult in earlier studies.40 The results
confirm long-lasting harmful effects of smoking during
pregnancy, and, independently, of smoking later in the
child’s life. Average, conservative effect estimates at school
age were not large, but exposures (particularly postnatal)
were widespread. The public health consequence for our
populations of children—and our future populations of
adults—remains a serious one.
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